Reuters logo
BRIEF-Geneuro publishes data supporting role of retroviral pathogenic envelope protein in type 1 diabetes
September 11, 2017 / 5:38 AM / 14 days ago

BRIEF-Geneuro publishes data supporting role of retroviral pathogenic envelope protein in type 1 diabetes

Sept 11 (Reuters) - GENEURO SA:

* GENEURO AND COLLABORATORS PUBLISH DATA SUPPORTING ROLE OF RETROVIRAL PATHOGENIC ENVELOPE PROTEIN IN TYPE 1 DIABETES (T1D)

* ‍GENEURO HAS INITIATED A RANDOMIZED, PLACEBO-CONTROLLED PHASE 2A STUDY TO EVALUATE GNBAC1 IN 60 RECENTLY DIAGNOSED ADULT PATIENTS​

* ‍PRIMARY ENDPOINT OF STUDY IS SAFETY OF GNBAC1 IN THIS NEW POPULATION OF PATIENTS​

* ‍SECONDARY ENDPOINTS WILL MEASURE LINK BETWEEN TREATMENT RESPONSE AND PHERV-W ENV BIOMARKERS OF PANCREATIC FUNCTION, INSULIN PRODUCTION

* PRELIMINARY RESULTS ARE EXPECTED DURING Q3 2018. Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below